Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
British Journal of Cancer
|
March 9, 2016
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
Andrew R Green, Mohammed A Aleskandarany, Devika Agarwal, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 24, 2019
PYK2 promotes HER2-positive breast cancer invasion
Shaymaa Ik Al-Juboori, Jayakumar Vadakekolathu, Sarra Idri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
Tarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
The British Journal of Radiology
|
November 13, 2015
Accuracy of GE digital breast tomosynthesis vs supplementary mammographic views for diagnosis of screen-detected soft-tissue breast lesions
Eleanor J Cornford, Anne E Turnbull, Jonathan J James, et al.
Genes, Chromosomes & Cancer
|
December 11, 2012
Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cells
Stéphanie A-S Laversin, Vinaya M Phatak, Des G Powe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2018
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
Alastair M Thompson, Karen Clements, Shan Cheung, et al.
Cell Death & Disease
|
August 12, 2016
Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation
Marta Bagnati, Babatunji W Ogunkolade, Catriona Marshall, et al.
The Journal of Pathology. Clinical Research
|
August 9, 2016
Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series
Andrew R Green, Daniele Soria, Jacqueline Stephen, et al.
The Lancet. Oncology
|
June 18, 2016
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis
Tarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, et al.
Cancer Research
|
April 16, 2009
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome
Somaia E Elsheikh, Andrew R Green, Emad A Rakha, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
British Journal of Cancer
|
March 9, 2016
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
Andrew R Green, Mohammed A Aleskandarany, Devika Agarwal, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 24, 2019
PYK2 promotes HER2-positive breast cancer invasion
Shaymaa Ik Al-Juboori, Jayakumar Vadakekolathu, Sarra Idri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
Tarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
The British Journal of Radiology
|
November 13, 2015
Accuracy of GE digital breast tomosynthesis vs supplementary mammographic views for diagnosis of screen-detected soft-tissue breast lesions
Eleanor J Cornford, Anne E Turnbull, Jonathan J James, et al.
Genes, Chromosomes & Cancer
|
December 11, 2012
Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cells
Stéphanie A-S Laversin, Vinaya M Phatak, Des G Powe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2018
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
Alastair M Thompson, Karen Clements, Shan Cheung, et al.
Cell Death & Disease
|
August 12, 2016
Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation
Marta Bagnati, Babatunji W Ogunkolade, Catriona Marshall, et al.
The Journal of Pathology. Clinical Research
|
August 9, 2016
Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series
Andrew R Green, Daniele Soria, Jacqueline Stephen, et al.
The Lancet. Oncology
|
June 18, 2016
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis
Tarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, et al.
Cancer Research
|
April 16, 2009
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome
Somaia E Elsheikh, Andrew R Green, Emad A Rakha, et al.
Page
of 4